The Efficacy of Gliatiline® on Post-stroke Patients With Vascular Cognitive Impairment no Dementia
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 222 participants.
Also called NCT01363648
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 222 participants
- Registry
-
NCT01363648
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01363648. Randomized; quadruple masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2013-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy of Gliatiline® on Post-stroke Patients With Vascular Cognitive Impairment no Dementia
- Acronym
- GLITTER
- Condition
- Cognitive Impairment
- Condition
- Stroke
- Intervention (Drug)
- choline alfoscerate
- Intervention (Drug)
- placebo (for choline alphoscerate)
- Lead sponsor
- Seoul National University Hospital
Record details
- Record id
cardio:ct-nct01363648- Content hash
5bc3540da8bb816b1ea4740c65872c64dcc666fed58cbbc3680f7e857e2451ee